Your cart is currently empty!
Retatrutide Research Dosages
Below are potential future clinical trial dosages that might be explored for weight loss research based on studies cited by other research.
*Administered subcutaneously 1x weekly
| Schedule | Weekly Dose in Milligrams (mg) | Weekly Dose Converted to Micrograms (mcg) |
| Week 1 – 4 | 2 mg | 2000 mcg |
| Week 5 – 8 | 4 mg | 4000 mcg |
| Week 9 – 12 | 8 mg | 8000 mcg |
| Week 13+ | 12 mg | 12000 mcg |
*NOTE: This dosage schedule is for educational, and research use only. Products purchased from omegapeps.com have not been approved by the FDA for clinical studies or trials involving humans or animals at this time.
Categories
- BPC-157
- CJC-1295 (with DAC)
- CJC-1295 No Dac
- Epithalon
- Follistatin
- General Peptide
- GHK-cu (Copper Peptide)
- GnRH (Gonadotropin-Releasing Hormone)
- HCG (Human Chorionic Gonadotropin)
- Ipamorelin
- Kisspeptin
- Melanotan II (MT2)
- MK-677 (Ibutamoren)
- MOTS-c
- NAD+
- Oxytocin
- Peptide Storage
- Peptides
- PT-141 (Bremelanotide)
- Research Dosages
- Research Supplies
- Retatrutide
- Selank
- Semaglutide
- TB500 (Thymosin Beta-4)
- Tirzepatide